Antiphospholipid-protein antibodies and acute ischemic stroke in the NINDS rt-PA Stroke Trial

Neurology. 2003 Oct 28;61(8):1158-9. doi: 10.1212/01.wnl.0000086809.46485.a1.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Antibodies, Anticardiolipin / blood
  • Antibodies, Antiphospholipid / blood*
  • Brain Ischemia / blood*
  • Brain Ischemia / drug therapy
  • Cerebral Hemorrhage / chemically induced
  • Disease Progression
  • Double-Blind Method
  • Glasgow Outcome Scale / statistics & numerical data
  • Humans
  • Injections, Intravenous
  • National Institutes of Health (U.S.) / statistics & numerical data
  • Odds Ratio
  • Predictive Value of Tests
  • Stroke / blood*
  • Stroke / drug therapy
  • Tissue Plasminogen Activator / adverse effects
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome
  • United States

Substances

  • Antibodies, Anticardiolipin
  • Antibodies, Antiphospholipid
  • Tissue Plasminogen Activator